Patient-Centred Models of Hepatitis C Treatment for PWID

To achieve World Health Organization targets for the elimination of hepatitis C virus (HCV) as a public threat, an increased uptake of HCV treatment among people who inject drugs (PWID) is urgently needed. Optimal HCV co-located treatment models for PWID have not yet been identified.

A study, published in The Lancet Gastroenterology & Hepatology, compared two patient-centred models of HCV care in PWID with active drug use at eight US cities in eight opioid treatment programmes and 15 community health centres.

Study summary can be accessed here.